Exploring Antibodies, Small Molecules & Nanoparticles for Increased Movement of Oligonucleotide Therapeutics Across the Blood Brain Barrier

Time: 1:00 pm
day: Day One


  • Uncovering considerations for each therapeutic modality from a therapeutic perspective
  • Exploring molecule design considerations for moving across the blood brain barrier more readily
  • Are there recommendations to consider for antibodies, small molecules, nanoparticles and peptides?